Paper29970809
Present and Future Therapy of Cryptococcus Infections.
Mourad A and 1 other. J Fungi (Basel), 2018. Cited by 43 papers, by iCite.
Cite this record
ConductScience Library. Present and Future Therapy of Cryptococcus Infections. Papers, record 29970809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29970809
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI073896 | NIAID NIH HHS | United States | R01AI073896 | PubMed | NIH RePORTER |
| R01 AI093257 | NIAID NIH HHS | United States | R01AI093257 | PubMed and NIH | NIH RePORTER |
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26753085 | Reversible Deafness and Blindness in a Patient with Cryptococcal Meningitis in Tanzania. | Infect Dis Rep | 2015 | https://conductscience.org/library/papers/26753085 | PubMed |
| 2 | 27664991 | Activity of VT-1129 against Cryptococcus neoformans clinical isolates with high fluconazole MICs. | Med Mycol | 2017 | https://conductscience.org/library/papers/27664991 | PubMed |
| 3 | 28783748 | Heat shock protein 90 localizes to the surface and augments virulence factors of Cryptococcus neoformans. | PLoS Negl Trop Dis | 2017 | https://conductscience.org/library/papers/28783748 | PubMed |
| 4 | 25422390 | Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012. | Clin Infect Dis | 2015 | https://conductscience.org/library/papers/25422390 | PubMed |
| 5 | 28201509 | In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen. | J Antimicrob Chemother | 2017 | https://conductscience.org/library/papers/28201509 | PubMed |
| 6 | 24020737 | Radioimmunotherapy of Cryptococcus neoformans spares bystander mammalian cells. | Future Microbiol | 2013 | https://conductscience.org/library/papers/24020737 | PubMed |
| 7 | 29507066 | Acylhydrazones as Antifungal Agents Targeting the Synthesis of Fungal Sphingolipids. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29507066 | PubMed |
| 8 | 20597693 | Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings. | Clin Infect Dis | 2010 | https://conductscience.org/library/papers/20597693 | PubMed |
| 9 | 15661940 | IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis. | J Immunol | 2005 | https://conductscience.org/library/papers/15661940 | PubMed |
| 10 | 1716613 | Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity. | Infect Immun | 1991 | https://conductscience.org/library/papers/1716613 | PubMed |
| 11 | 27169478 | Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses. | Clin Infect Dis | 2016 | https://conductscience.org/library/papers/27169478 | PubMed |
| 12 | 29190379 | Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus. | J Antimicrob Chemother | 2018 | https://conductscience.org/library/papers/29190379 | PubMed |
| 13 | 24675586 | Cryptococcal meningitis management in Tanzania with strict schedule of serial lumber punctures using intravenous tubing sets: an operational research study. | J Acquir Immune Defic Syndr | 2014 | https://conductscience.org/library/papers/24675586 | PubMed |
| 14 | 11069257 | The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans. | J Infect Dis | 2000 | https://conductscience.org/library/papers/11069257 | PubMed |
| 15 | 18524882 | Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan. | Clin Vaccine Immunol | 2008 | https://conductscience.org/library/papers/18524882 | PubMed |
| 16 | 20047480 | Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. | Clin Infect Dis | 2010 | https://conductscience.org/library/papers/20047480 | PubMed |
| 17 | 10972493 | Melanin and virulence in Cryptococcus neoformans. | Curr Opin Microbiol | 2000 | https://conductscience.org/library/papers/10972493 | PubMed |
| 18 | 1313682 | Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. | AIDS | 1992 | https://conductscience.org/library/papers/1313682 | PubMed |
| 19 | 29234588 | Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis. | Med Mycol Case Rep | 2018 | https://conductscience.org/library/papers/29234588 | PubMed |
| 20 | 24900384 | Antifungal spectrum, in vivo efficacy, and structure-activity relationship of ilicicolin h. | ACS Med Chem Lett | 2012 | https://conductscience.org/library/papers/24900384 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41595640 | Targeting Yeast Pathogens with Lectins: A Narrative Review from Mechanistic Insights to the Need for Addressing Translational Challenges. | Biomedicines | 2026 | https://conductscience.org/library/papers/41595640 | PubMed |
| 40881815 | Extracellular Vesicles From Fungal Infection in Humans: A Key Player in Immunological Responses. | J Extracell Biol | 2025 | https://conductscience.org/library/papers/40881815 | PubMed |
| 40376381 | Cryptococcal Meningoencephalitis With Herpes Zoster Coinfection in a Retrovirus-Positive Adolescent Male With a Normal CD4 Count: A Rare Case. | Cureus | 2025 | https://conductscience.org/library/papers/40376381 | PubMed |
| 39464491 | Cryptococcal Meningitis in an HCV-Positive and IVDU- and HIV-Negative Patient: A Case Report and Literature Review. | Int Med Case Rep J | 2024 | https://conductscience.org/library/papers/39464491 | PubMed |
| 39365015 | Fulminant Meningitis: A Rare Case of HSV-2 and Cryptococcal Co-Infection in a Patient With AIDS. | J Investig Med High Impact Case Rep | 2024 | https://conductscience.org/library/papers/39365015 | PubMed |
| 38324809 | Case report: First case of fungemia caused by Papiliotrema laurentii in a patient with SARS-CoV-2 infection. | Rev Soc Bras Med Trop | 2024 | https://conductscience.org/library/papers/38324809 | PubMed |
| 38305394 | Molecular Pathway, Epidemiological Data and Treatment Strategies of Fungal Infection (Mycoses): A Comprehensive Review. | Cent Nerv Syst Agents Med Chem | 2024 | https://conductscience.org/library/papers/38305394 | PubMed |
| 37998390 | Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species. | Cells | 2023 | https://conductscience.org/library/papers/37998390 | PubMed |
| 37950840 | Synergistic effect of the verapamil and amphotericin B against Cryptococcus neoformans. | Folia Microbiol (Praha) | 2023 | https://conductscience.org/library/papers/37950840 | PubMed |
| 36960287 | Synergistic antifungal interaction of N-(butylcarbamothioyl) benzamide and amphotericin B against Cryptococcus neoformans. | Front Microbiol | 2023 | https://conductscience.org/library/papers/36960287 | PubMed |
| 36815840 | Organoselenium Has a Potent Fungicidal Effect on Cryptococcus neoformans and Inhibits the Virulence Factors. | Antimicrob Agents Chemother | 2023 | https://conductscience.org/library/papers/36815840 | PubMed |
| 36748523 | Do mitochondria use efflux pumps to protect their ribosomes from antibiotics? | Microbiology (Reading) | 2023 | https://conductscience.org/library/papers/36748523 | PubMed |
| 36229573 | Vaccine protection by Cryptococcus neoformans Δsgl1 is mediated by γδ T cells via TLR2 signaling. | Mucosal Immunol | 2022 | https://conductscience.org/library/papers/36229573 | PubMed |
| 35972650 | Antifungal and Antibiofilm In Vitro Activities of Ursolic Acid on Cryptococcus neoformans. | Curr Microbiol | 2022 | https://conductscience.org/library/papers/35972650 | PubMed |
| 35615354 | Three Models of Vaccination Strategies Against Cryptococcosis in Immunocompromised Hosts Using Heat-Killed Cryptococcus neoformans Δsgl1. | Front Immunol | 2022 | https://conductscience.org/library/papers/35615354 | PubMed |
| 35472450 | Role of the anillin-like protein in growth of Cryptococcus neoformans at human host temperature. | Fungal Genet Biol | 2022 | https://conductscience.org/library/papers/35472450 | PubMed |
| 35335969 | Synthesis and Evaluation of the Antifungal and Toxicological Activity of Nitrofuran Derivatives. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35335969 | PubMed |
| 34829198 | Molecular Mechanisms of 5-Fluorocytosine Resistance in Yeasts and Filamentous Fungi. | J Fungi (Basel) | 2021 | https://conductscience.org/library/papers/34829198 | PubMed |
| 34568097 | Cryptococcus neoformans Δsgl1 Vaccination Requires Either CD4+ or CD8+ T Cells for Complete Host Protection. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/34568097 | PubMed |
| 34467755 | Docusate-Based Ionic Liquids of Anthelmintic Benzimidazoles Show Improved Pharmaceutical Processability, Lipid Solubility, and in Vitro Activity against Cryptococcus neoformans. | ACS Infect Dis | 2021 | https://conductscience.org/library/papers/34467755 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CALM1 | 801 | PubTator's text mining | https://conductscience.org/library/genes/801 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CXCL8 | 3576 | PubTator's text mining | https://conductscience.org/library/genes/3576 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29970809
GET https://conductscience.org/api/papers/v1/29970809/references?page=2